Nancy T Chang - Net Worth and Insider Trading
Nancy T Chang Net Worth
The estimated net worth of Nancy T Chang is at least $323,562 dollars as of 2024-11-10. Nancy T Chang is the Director of SciClone Pharmaceuticals Inc and owns about 29,019 shares of SciClone Pharmaceuticals Inc (SCLN) stock worth over $323,562. Details can be seen in Nancy T Chang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy T Chang has not made any transactions after 2016-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nancy T Chang
Nancy T Chang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy T Chang owns 6 companies in total, including Helix Acquisition Corp (HLXA) , SciClone Pharmaceuticals Inc (SCLN) , and Charles River Laboratories International Inc (CRL) among others .
Click here to see the complete history of Nancy T Chang’s form 4 insider trades.
Insider Ownership Summary of Nancy T Chang
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HLXA | Helix Acquisition Corp | 2020-10-19 | director |
SCLN | SciClone Pharmaceuticals Inc | 2017-10-13 | director |
CRL | Charles River Laboratories International Inc | 2009-05-08 | director |
2010-04-30 | director | ||
2020-10-19 | director | ||
2023-04-28 | director |
Nancy T Chang Latest Holdings Summary
Nancy T Chang currently owns a total of 1 stock. Nancy T Chang owns 29,019 shares of SciClone Pharmaceuticals Inc (SCLN) as of August 30, 2016, with a value of $323,562.
Latest Holdings of Nancy T Chang
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SCLN | SciClone Pharmaceuticals Inc | 2016-08-30 | 29,019 | 11.15 | 323,562 |
Holding Weightings of Nancy T Chang
Nancy T Chang Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy T Chang has made a total of 0 transactions in SciClone Pharmaceuticals Inc (SCLN) over the past 5 years. The most-recent trade in SciClone Pharmaceuticals Inc is the sale of 25,040 shares on August 30, 2016, which brought Nancy T Chang around $257,912.
Insider Trading History of Nancy T Chang
- 1
Nancy T Chang Trading Performance
Nancy T Chang Ownership Network
Ownership Network List of Nancy T Chang
Ownership Network Relation of Nancy T Chang
Nancy T Chang Owned Company Details
What does Helix Acquisition Corp do?
Who are the key executives at Helix Acquisition Corp?
Nancy T Chang is the director of Helix Acquisition Corp. Other key executives at Helix Acquisition Corp include director & 10 percent owner & CEO and Chairman Bihua Chen , director & 10 percent owner Helix Holdings Llc , and Chief Financial Officer Jay Scollins .
Helix Acquisition Corp (HLXA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Helix Acquisition Corp (HLXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Helix Acquisition Corp (HLXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Helix Acquisition Corp (HLXA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Helix Acquisition Corp Insider Transactions
Nancy T Chang Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy T Chang. You might contact Nancy T Chang via mailing address: 101 Westcott, Suite 603, Houston Tx 77007.